EU MDR: Extending the Transition Period for Medical Devices

by | Feb 7, 2023 | EU MDR, FDA, Medical Devices, Regulatory

The European Commission has implemented a proposal to extend the transitional period to certify medical devices under the Medical Devices Regulation (MDR). The proposal allows more time for manufacturers to transition from the previously applicable rules to the new requirements of the Regulation1. 

For high-risk devices, the transition period to the new rules will be shorter (extended to December 31, 2027), whereas the medium and lower risk devices will have a longer transition period (extended to December 31, 2028). The proposal also introduces a transition period for Class III implantable custom-made devices. Manufacturers will have until May 26, 2026 to certify such devices2

A plan to remove the “sell-off” date has been proposed by the Commission. In the current MDR, it establishes that the “sell-off” date is the end date where devices that are already in the market, should be disposed or withdrawn. Deletion of the “sell-off’ date will prevent the removal of some safe medical devices that are essential to the market as well as alleviating the risk of product shortages. 

Next steps, the proposal will need to be considered and adopted by the European Parliament and the Council through an accelerated co-decision procedure. 

If you need support to successfully transition to EU MDR, the experts at EMMA International can help! Contact us at 248-987-4497 or email us at info@emmainternational.com to learn

Ali Al-Dieri

Ali Al-Dieri

Ali is a Regulatory Scientist at EMMA International. He has experience in sterile injectable drug products and active pharmaceutical ingredient (API) manufacturing. Additionally, Ali has experience in quality assurance, regulatory compliance, process validation, and academic experience in molecular biology and immunology. Ali attended the University of Toledo where here received a Bachelor of Pharmaceutical Sciences in Pharmacology &Toxicology, a Masters in Pharmaceutical Sciences in Pharmacology & Toxicology, and a Ph.D in Medicinal and Biological Chemistry.

More Resources

Change Management And Control

Change Management And Control

One of the biggest and most important aspects of quality management is a system to monitor changes and how they impact the product. Change management is an approach for changing processes or products in a way which adheres to regulatory standards by ensuring stability and consistency throughout processes. It applies across all changes within a process and throughout an entire products life cycle.
Aseptic Technique and Gowning

Aseptic Technique and Gowning

One of the most common techniques to prevent contamination of products and reduce quality impacts in the pharmaceutical industry is called aseptic gowning. Humans are the biggest sources of microbial contamination in cleanroom environments and therefore proper gowning procedures are essential to ensuring product quality. Proper training, education, hygiene, qualification, and authorization must be put in place and be required for entry to all clean room environments...
Importance of Pharmaceutical GMP

Importance of Pharmaceutical GMP

Having high quality standards is vital to any organization but is even more essential in the pharmaceutical industry. Practices that are governed by these standards are commonly called Good Manufacturing Practices (GMP) and ensure consistent and controlled production of products. These practices govern all aspects and procedures within production and provide documented proof that procedures are consistently followed during the manufacturing processes every time products are made. They are designed to minimize risks throughout the manufacturing process that are not able to be eliminated in final product testing so that pharmaceuticals are safe for use...

Ready to learn more about working with us?

Pin It on Pinterest

Share This